EGFR and lung carcinoma: It is identified by Lin and colleagues that METTL3 boosts translation of certain mRNAs including epidermal growth factor receptor (EGFR) and the Hippo pathway effector TAZ, thus promoting growth, survival, and invasion of human lung cancer cells.